Crow Y J, Black D N, Ali M, Bond J, Jackson A P, Lefson M, Michaud J, Roberts E, Stephenson J B P, Woods C G, Lebon P
Molecular Medicine Unit, University of Leeds, St James's University Hospital, Leeds, UK.
J Med Genet. 2003 Mar;40(3):183-7. doi: 10.1136/jmg.40.3.183.
Aicardi-Goutiéres syndrome (AGS) is an early onset, progressive encephalopathy characterised by calcification of the basal ganglia, white matter abnormalities, and a chronic cerebrospinal fluid (CSF) lymphocytosis. Cree encephalitis shows phenotypic overlap with AGS although the conditions have been considered distinct because of immunological abnormalities observed in Cree encephalitis. We report that levels of interferon alpha (IFN-alpha), a marker of AGS, are raised in Cree encephalitis. Moreover, linkage analysis indicates that the disorders are allelic and refines the AGS1 locus to a 3.47 cM critical interval. Our data show that a CSF lymphocytosis is not necessary for the diagnosis of AGS and strongly suggest that AGS and pseudo-TORCH syndrome are the same disorder. Recognition of immunological dysfunction as part of the AGS phenotype provides further evidence of a primary pathogenic role for abnormal IFN-alpha production in AGS.
艾卡迪-古铁雷斯综合征(AGS)是一种早发性进行性脑病,其特征为基底神经节钙化、白质异常以及慢性脑脊液(CSF)淋巴细胞增多。克里脑炎与AGS存在表型重叠,尽管由于在克里脑炎中观察到的免疫异常,这两种疾病一直被认为是不同的。我们报告称,作为AGS标志物的α干扰素(IFN-α)水平在克里脑炎中升高。此外,连锁分析表明这两种疾病是等位基因疾病,并将AGS1基因座精细定位到一个3.47厘摩的关键区间。我们的数据表明,CSF淋巴细胞增多并非AGS诊断所必需,并且强烈提示AGS和假性TORCH综合征是同一种疾病。将免疫功能障碍识别为AGS表型的一部分,为异常IFN-α产生在AGS中的原发性致病作用提供了进一步证据。